| Business Type | Exporter, Supplier, Retailer, Distributor, Importer |
| Feature | As A Result, Mounjaro Lowers Both Fasting And Post‑meal (postprandial) Glucose Levels. Guideline Ce |
| Purity | Excipients / Non‑active Ingredients (in The 0.5 ML Solution) Include: Sodium Chloride, Sodium Phosph |
| Usage | Administration: Once Weekly, By Subcutaneous Injection (under The Skin), In The Abdomen, Thigh, Or U |
| Click to view more | |
Product Details
Dosage Form
Sterile Solution For Subcutaneous Injection, Pre-filled Pen Or Single-dose Vial
Form
Liquid Solution Pre-filled Injection Pen
Color
Clear, Colorless Solution In Pre-filled Pen Pen Casing: Typically Light Gray Or White With Labeled
Brand Name
Mounjaro®
Origin
Manufactured In USA / Eli Lilly Facilities Under CGMP Standards
Mounjaro® is a prescription medication that contains tirzepatide, a dual GIP/GLP-1 receptor agonist. It is approved for the management of type 2 diabetes mellitus in adults. It improves blood sugar control by enhancing insulin secretion, reducing glucagon, and slowing gastric emptying.
Looking for "15mg Mounjaro Tirzepatide Injection" ?
Box
